HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
TLRY
Tilray Brands Inc
Healthcare Drug Manufacturers - Specialty & Generic · British Columbia, Canada · Reports in usd
Market Cap: $791.1M
Market Cap
$791.1M
Enterprise Val
$843.3M
P/E Ratio
-0.59
P/B Ratio
0.51
Trailing PEG (1Y)
0.01
As Of
Apr 15, 2026

Overview & Key Metrics

Reporting period: Feb 28, 2026 · Q3 2026
Book Value$1.53B
Gross Margin26.58%
Profit Margin26.58%
Return on Equity-86.93%
Return on Assets-64.59%
Current Ratio2.79
Debt/Equity0.20
LT Debt/Equity0.18
Revenue Per Share1.77

Income Statement

Feb 28, 2026
Revenue$206.7M
Cost of Revenue$151.8M
Gross Profit$55.0M
R&D$62.0K
SG&A$69.5M
Operating Expenses$81.3M
Operating Income-$26.4M
Interest Expense$5.0M
Tax Expense$2.0M
Net Income-$26.6M
EPS (Basic)$-0.24
EPS (Diluted)$-0.24
EBIT-$19.6M
EBITDA-$2.9M
Consolidated Income-$25.2M
Non-Controlling Interests$1.3M

Balance Sheet

Feb 28, 2026
Cash & Equivalents$249.5M
Accounts Receivable$118.4M
Inventory$292.3M
Current Assets$718.8M
LT Investments$8.2M
Property, Plant & Equipment$560.9M
Intangibles$775.7M
Non-Current Assets$1.36B
Total Assets$2.07B
Accounts Payable$224.0M
Current Debt$33.5M
Current Liabilities$257.5M
LT Debt$283.5M
Non-Current Liabilities$291.6M
Total Liabilities$549.1M
Total Debt$317.1M
Retained Earnings-$4.92B
Shareholder Equity$1.56B
Shares Outstanding116,506,916

Cash Flow Statement

Feb 28, 2026
Operating Cash Flow-$21.9M
Investing Cash Flow$28.9M
Financing Cash Flow-$5.1M
CapEx-$2.2M
Free Cash Flow-$24.2M
Depreciation & Amort.$16.7M
Stock-Based Comp$13.7M
Acquisitions / Disposals$0.00
Investment Activity$31.2M
Debt Issued/Repaid-$5.0M
Equity Issued/Repaid-$159.0K
Dividends Paid$0.00
Net Change in Cash$2.8M
Data cached · Meta live · Daily live · Statements live · TTL 24h